2012
DOI: 10.1016/j.biomaterials.2012.07.022
|View full text |Cite
|
Sign up to set email alerts
|

PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes

Abstract: Macrophages within the tumor microenvironment (TAMs) have been shown to play a major role in the growth and spread of many types of cancer. Cancer cells produce cytokines that cause macrophages to express scavenger receptors (e.g. the mannose receptor) and factors that facilitate tissue and blood vessel growth, suppress T cell mediated anti-tumor activity, and express enzymes that can break down the extracellular matrix, thereby promoting metastasis. We have designed a mannosylated liposome (MAN-LIPs) and show… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
133
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 117 publications
(133 citation statements)
references
References 39 publications
0
133
0
Order By: Relevance
“…[7][8][9][10][11][12] So far, only a few ionophore assisted loading (IAL) procedures have been developed for liposomal PET imaging applications. 1,12,13 Despite the generally high loading efficiencies, high radionuclide retention, rapid loading kinetics and successful in vivo liposomal performance there are disadvantages of using transporter molecules such as ionophores or lipophilic chelators (hereafter referred to as ionophores as a common term) for remote loading of radionuclides into liposomes. One drawback to consider is the penalty in Gibbs free energy, which derives from stripping the radionuclide from the ionophore upon transfer to the liposome-entrapped chelator (Figure 1, right).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[7][8][9][10][11][12] So far, only a few ionophore assisted loading (IAL) procedures have been developed for liposomal PET imaging applications. 1,12,13 Despite the generally high loading efficiencies, high radionuclide retention, rapid loading kinetics and successful in vivo liposomal performance there are disadvantages of using transporter molecules such as ionophores or lipophilic chelators (hereafter referred to as ionophores as a common term) for remote loading of radionuclides into liposomes. One drawback to consider is the penalty in Gibbs free energy, which derives from stripping the radionuclide from the ionophore upon transfer to the liposome-entrapped chelator (Figure 1, right).…”
Section: Introductionmentioning
confidence: 99%
“…Common practice is therefore to use ionophores to increase the trans-membrane ion diffusion rate, and thereby improve the loading kinetics of charged ions such as radionuclides into liposomes. [7][8][9][10][11][12][13] Despite previous knowledge and findings within this field, the present work describes a novel loading method of the PET radionuclide 64 Cu 2+ into liposomes, excluding the use of ionophores (an unassisted loading). In this method, 64 Cu 2+ (or copper) is added to preformed liposomes entrapping a high affinity copper chelator (Figure 1, left).…”
Section: Introductionmentioning
confidence: 99%
“…Within cell-tracking studies featuring either iron oxide-mediated MR imaging (29,30) or radionuclide imaging, for example, using 64 Cu-liposome labels for PET (31), the abundance of macrophages and other phagocytes in the tumor microenvironment could already be shown. Within this study, we present an approach for visualization of monocyte activity beyond sheer abundance in the primary tumor.…”
Section: Discussionmentioning
confidence: 99%
“…To avoid recognition by peripheral macrophages, some studies have dealt with the shield of surface-decorated nanocarriers using polymers that degrade due to environmental changes in the tumor microenvironment, such as a more acidic pH (Huang et al 2012 ;Zhu et al 2013 ). Biomarkers aberrantly expressed at the surface of TAMs include the mannose receptor (Movahedi et al 2012 ;Locke et al 2012 ;Zhu et al 2013 ), the galactose-type lectin (Mgl) receptor (Huang et al 2012 ), the folate receptor beta ( Nagai et al 2009 ), scavenger receptors such as CD163 ( Etzerodt et al 2012 ), and legumain (Luo et al 2006 ;Gomez-Cabrero et al 2013 ;Zhang et al 2013 ).…”
Section: Nanocarriers Targeted To Tamsmentioning
confidence: 98%